Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comments on "first-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis"
Helminth/Parasite treatment of multiple sclerosis.
SIRT1 Promotes RGC Survival and Delays Loss of Function Following Optic Nerve Crush.
Teaching NeuroImages: Cerebral white matter involvement in a patient with Vogt-Koyanagi-Harada syndrome.
Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.
Bevacizumab is safe in acute relapses of neuromyelitis optica.
Neuromyelitis optica spectrum disorder associated with osmotic demyelination syndrome.
Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis.
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders.
The influence of immunomodulatory treatment on the clinical course of multiple sclerosis.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Paediatric multiple sclerosis: a qualitative study of families' diagnosis experiences.
Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial.
The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.
Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood.
The gender-specific association of CXCL16 A181V gene polymorphism with susceptibility to multiple sclerosis, and its effects on PBMC mRNA and plasma soluble CXCL16 levels: preliminary findings.
Olfactory Dysfunction in Multiple Sclerosis: Evidence of a Decrease in Different Aspects of Olfactory Function.
Looking out for the blind spot.
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.
The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.
[Animal model of neuromyelitis optica].
Preface: Perspectives of an MS Researcher.
A critical role for interleukin-1β in the progression of autoimmune diseases.
Pages
« first
‹ previous
…
639
640
641
642
643
644
645
646
647
…
next ›
last »